Clinical trials

Motorcycles wearing face masks to help curb the spread of the new coronavirus wait at a stoplight in Bangkok, Thailand, Tuesday, May 26, 2020. (AP Photo/Sakchai Lalit)
May 26, 2020 - 7:38 am
BANGKOK (AP) — As about 24,000 Filipinos who lost their jobs abroad are being transported by land, sea or air to their provincial homes, the president warned local officials not to refuse them entry out of coronavirus fears. The workers returned to the country in recent months as jobs dried up...
Read More
May 25, 2020 - 8:35 pm
CANBERRA, Australia (AP) — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and...
Read More
FILE - This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. The World Health Organization said Monday May 25, 2020, that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments because its experts need to review all available evidence. (AP Photo/David J. Phillip, File)
May 25, 2020 - 1:46 pm
GENEVA (AP) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to...
Read More
May 21, 2020 - 3:23 am
GENEVA (AP) — The World Health Organization, which has come under repeated fire from U.S. President Donald Trump, says the science is still unclear on an old malaria drug he's taking to try to defend against the novel coronavirus. It says it recommends the drug's use for COVID-19 only in controlled...
Read More
A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. President Donald Trump’s declaration that he was taking the antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating cases of the coronavirus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19. (AP Photo/Rafiq Maqbool)
May 19, 2020 - 8:50 pm
NEW DELHI (AP) — President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring...
Read More
Veterans Affairs Secretary Robert Wilkie speaks about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 16, 2020 - 12:14 am
WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans with COVID-19 but that fewer of its patients are now taking it. In responses provided to Congress and obtained by The Associated Press, the VA...
Read More
FILE - In this March 16, 2020 file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. In a press briefing on Thursday May 14, 2020, the European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” (AP Photo/Ted S. Warren, File)
May 14, 2020 - 7:19 am
LONDON (AP) — The European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” Dr. Marco Cavaleri, who heads the European regulator’s vaccines department...
Read More
In this screen grab from video issued by Britain's Oxford University, a volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine, led by Oxford University in England on April 25, 2020. About 100 research groups around the world are pursuing vaccines against the coronavirus, with nearly a dozen in early stages of human trials or poised to start. (University of Oxford via AP)
May 04, 2020 - 1:14 am
WASHINGTON (AP) — Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated. About 100 research groups are...
Read More
FILE - In this March 16, 2020, file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. A coronavirus vaccine is still months or years away, but groups that peddle misinformation about immunizations are already taking aim -- and potentially eroding -- confidence in what could be humanity’s best chance to defeat the virus. (AP Photo/Ted S. Warren, File)
WBEN Newsroom
April 29, 2020 - 1:31 am
NEW YORK (AP) — A coronavirus vaccine is still months or years away, but groups that peddle misinformation about immunizations are already taking aim, potentially eroding confidence in what could be humanity’s best chance to defeat the virus. In recent weeks, vaccine opponents have made several...
Read More
FILE - This Monday, April 6, 2020, file photo shows an arrangement of Hydroxychloroquine pills in Las Vegas. At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat COVID-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. (AP Photo/John Locher,File)
April 24, 2020 - 9:05 pm
SALT LAKE CITY (AP) — State and local governments across the United States have obtained about 30 million doses of a malaria drug touted by President Trump to treat patients with the coronavirus, despite warnings from doctors that more research is needed. At least 22 states and Washington, D.C.,...
Read More

Pages